Literature DB >> 12920559

Permanent interstitial brachytherapy for prostate cancer: a current review.

Jeffrey Woolsey1, Nicole Miller, Dan Theodorescu.   

Abstract

Prostate brachytherapy with permanent radioactive implants is becoming an increasingly popular treatment choice for patients with prostate cancer. This therapy is attractive to patients due to the fact that it is an outpatient procedure and in many cases has been associated with lower long-term risks of urinary incontinence and erectile dysfunction when compared to other curative modalities. This review will describe the history, isotopes used, implantation techniques, and results achieved with modern prostate brachytherapy. Results will be discussed both in terms of cancer control and health-related quality of life endpoints.

Entities:  

Mesh：

Year:  2003        PMID： 12920559     DOI： 10.1007/s00345-003-0357-9

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


  92 in total

Review 1.  Brachytherapy versus radical prostatectomy.

Authors:  V Ravery
Journal:  BJU Int       Date:  2001-01       Impact factor: 5.588

Review 2.  The role of high-dose rate brachytherapy in locally advanced prostate cancer.

Authors:  Frank A Vicini; Carlos Vargas; Gregory Edmundson; Larry Kestin; Alvaro Martinez
Journal:  Semin Radiat Oncol       Date:  2003-04       Impact factor: 5.934

3.  CT-based dosimetry for transperineal I-125 prostate brachytherapy.

Authors:  J Willins; K Wallner
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-09-01       Impact factor: 7.038

4.  Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer.

Authors:  M J Zelefsky; W F Whitmore
Journal:  J Urol       Date:  1997-07       Impact factor: 7.450

5.  Three-dimensional real-time magnetic resonance-guided interstitial prostate brachytherapy optimizes radiation dose distribution resulting in a favorable acute side effect profile in patients with clinically localized prostate cancer.

Authors:  M D Hurwitz; R Cormack; C M Tempany; S Kumar; A V D'Amico
Journal:  Tech Urol       Date:  2000-06

6.  Three-dimensional stereotactic posterior ischiorectal space computerized tomography guided brachytherapy of prostate cancer: a preliminary report.

Authors:  P G Koutrouvelis
Journal:  J Urol       Date:  1998-01       Impact factor: 7.450

7.  Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer.

Authors:  M J Zelefsky; T Hollister; A Raben; S Matthews; K E Wallner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-07-15       Impact factor: 7.038

8.  Erectile function after permanent prostate brachytherapy.

Authors:  Gregory S Merrick; Wayne M Butler; Robert W Galbreath; Robin L Stipetich; Laurie J Abel; Jonathan H Lief
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-03-15       Impact factor: 7.038

9.  Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up.

Authors:  H Ragde; J C Blasko; P D Grimm; G M Kenny; J Sylvester; D C Hoak; W Cavanagh; K Landin
Journal:  Semin Surg Oncol       Date:  1997 Nov-Dec

10.  A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.

Authors:  G S Merrick; W M Butler; A T Dorsey; J H Lief; J G Donzella
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-11-01       Impact factor: 7.038
View more
  2 in total

1.  Brachytherapy using injectable seeds that are self-assembled from genetically encoded polypeptides in situ.

Authors:  Wenge Liu; Jonathan McDaniel; Xinghai Li; Daisuke Asai; Felipe Garcia Quiroz; Jeffery Schaal; Ji Sun Park; Michael Zalutsky; Ashutosh Chilkoti
Journal:  Cancer Res       Date:  2012-11-15       Impact factor: 12.701

Review 2.  Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment.

Authors:  Cem Akbal; Ilker Tinay; Ferruh Simşek; Levent N Turkeri
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.